Skip to main content

Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Publication ,  Other
Ludwig, AL; McKay, ZP; Carter, GP; Katz, MA; Howell, G; Jain, V; Arvai, S; Dittmer, DP; Bigner, DD; Ashley, DM; Shoaf, ML; Desjardins, A ...
February 3, 2026

<p>Supplementary Figure S3. Dual-site (IT+CPLI) PVSRIPO in CT2A-bearing mice changes immune cell composition in cLN (extended data relating to Figure 3).</p>

Duke Scholars

DOI

Publication Date

February 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ludwig, A. L., McKay, Z. P., Carter, G. P., Katz, M. A., Howell, G., Jain, V., … Gromeier, M. (2026). Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. https://doi.org/10.1158/2326-6066.31239128
Ludwig, Andrea L., Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, et al. “Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration,” February 3, 2026. https://doi.org/10.1158/2326-6066.31239128.
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M. Supplementary Figure S3 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. 2026.

DOI

Publication Date

February 3, 2026